AN CAML BINDENDER LYMPHOZYTEOBERFLÄCHENREZEPTOR, NUKLEINSÄUREN DIE DAFÜR KODIEREN UND VERFAHREN ZUR VERWENDUNG

There is provided an isolated polypeptide comprising a fragment of a Transmembrane Activator and CAML-Interactor (TACI) protein comprising an N-terminal fragment of the TACI protein comprising the ligand-binding domain.

Saved in:
Bibliographic Details
Main Authors BRAM, RICHARD, VON BULOW, GOTZ
Format Patent
LanguageGerman
Published 15.09.2007
Subjects
AGRICULTURE
ANIMAL HUSBANDRY
BEER
BIOCHEMISTRY
CARE OF BIRDS, FISHES, INSECTS
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
FISHING
FORESTRY
HUMAN NECESSITIES
HUNTING
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NEW BREEDS OF ANIMALS
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR
SPIRITS
TESTING
TRAPPING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:There is provided an isolated polypeptide comprising a fragment of a Transmembrane Activator and CAML-Interactor (TACI) protein comprising an N-terminal fragment of the TACI protein comprising the ligand-binding domain.
Bibliography:Application Number: AT19980908948T